Skip to main content

Peer Review reports

From: Selumetinib suppresses cell proliferation, migration and trigger apoptosis, G1 arrest in triple-negative breast cancer cells

Original Submission
11 Sep 2015 Submitted Original manuscript
14 Nov 2015 Reviewed Reviewer Report - RAMESH Thylur PUTTALINGAIAH
29 Dec 2015 Reviewed Reviewer Report - Manoj Kumar Pandey
14 Mar 2016 Author responded Author comments - Yan Zhou
Resubmission - Version 2
14 Mar 2016 Submitted Manuscript version 2
20 Mar 2016 Reviewed Reviewer Report - RAMESH Thylur PUTTALINGAIAH
18 Apr 2016 Reviewed Reviewer Report - Manoj Kumar Pandey
10 May 2016 Author responded Author comments - Yan Zhou
Resubmission - Version 3
10 May 2016 Submitted Manuscript version 3
10 Jul 2016 Author responded Author comments - Yan Zhou
Resubmission - Version 4
10 Jul 2016 Submitted Manuscript version 4
23 Aug 2016 Author responded Author comments - Yan Zhou
Resubmission - Version 5
23 Aug 2016 Submitted Manuscript version 5
Publishing
8 Sep 2016 Editorially accepted
21 Oct 2016 Article published 10.1186/s12885-016-2773-4

You can find further information about peer review here.

Back to article page